Recent news
January 2012
GHTC member seeks projects to propel malaria drug discovery
January 18, 2012 -- Medicines for Malaria Venture (MMV)—a GHTC member working to discover, develop, and deliver antimalarial drugs—has issued a call for proposals to help spur malaria drug discovery. The organization will award up to ten $50,000 MMV Challenge Grants in the first quarter of 2012.
MMV is seeking projects that will help address key areas to work toward malaria eradication. According to the official call for proposals from MMV, three specific challenges are being issued:
- Screening: Testing the MMV Malaria Box against malaria and other parasitological assays. The Malaria Box is an open access resource that contains 400 diverse compounds with antimalarial activity.
- Medicinal chemistry: Performing hit-to-lead or optimization chemistry on any antimalarial series.
- Translational and clinical development: Identifying new methods to study or validate the inhibition of Plasmodium vivax relapses or the interruption of transmission.
